Treatment of Anthrax Disease Frequently Asked Questions
This document provides a summary of Frequently Asked Questions (FAQs) on the treatment of anthrax disease caused by a wide-area release of Bacillus anthracis spores as an act bioterrorism. These FAQs are intended to provide the public health and medical community, as well as others, with guidance and communications to support the response and long-term recovery from an anthrax event.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (US)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RL01830
- OSTI ID:
- 992013
- Report Number(s):
- PNNL-18710; 400403909
- Country of Publication:
- United States
- Language:
- English
Similar Records
Detecting anthrax in the palm of your hand: applications of a smartphone microscope
One Health Assessment of Bacillus anthracis Incidence and Detection in Anthrax-Endemic Areas of Pakistan
EPAct Alternative Fuel Transporation Program - State and Alternative Fuel Provider Fleets: Frequently Asked Questions
Journal Article
·
Fri Nov 13 23:00:00 EST 2015
· Atlas of Science
·
OSTI ID:1227595
One Health Assessment of Bacillus anthracis Incidence and Detection in Anthrax-Endemic Areas of Pakistan
Journal Article
·
Sat Sep 30 00:00:00 EDT 2023
· Microorganisms
·
OSTI ID:2368755
EPAct Alternative Fuel Transporation Program - State and Alternative Fuel Provider Fleets: Frequently Asked Questions
Program Document
·
Sun Feb 28 23:00:00 EST 2010
·
OSTI ID:1218478